Identification and characterization of novel somatostatin antagonists [published erratum appears in Mol Pharmacol 1997 Jan;51(1):170]

RT Bass, BL Buckwalter, BP Patel, MH Pausch, LA Price, J Strnad and JR Hadcock

Cyenamid Agricultural Research Center, Princeton, NJ 08543-0400, USA.

The study of the five somatostatin receptor subtypes (SSTx, where x is the subtype number) has been hampered by the lack of high affinity antagonists. Potent and selective antagonists would increase our understanding of SST structure, function, and regulation. In this study, the identification of novel disulfide-linked cyclic octapeptide antagonists of somatostatin is described. The antagonists contain a core structure of a DL-cysteine pair at positions 2 and 7 of the peptides. Substitution of a D-cysteine at position 2 with an L-cysteine converts the full antagonist into a full agonist. All somatostatin receptor subtypes are coupled to inhibition of adenylate cyclase. The functional properties of these peptides have been determined in radioligand binding assays, in functional coupling of the SST2 subtype to yeast pheromone response pathway, and in cAMP accumulations. One peptide antagonist [Ac-4-NO2-Phe-c(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr- NH2] displays a binding affinity to SST2 comparable with that observed for the native hormone (Ki = 0.2 nM) and reverses somatostatin-mediated inhibition of cAMP accumulation in rat somatomammotroph GH4C1 cells, cells transfected with the SST2 and SST5 subtypes, as well as somatostatin-stimulated growth of yeast cells expressing the SST2 subtype. This class of somatostatin antagonists, which are the first to be described, should be useful for determination of somatostatin's diverse functions in vivo and in vitro.

Volume 50, Issue 4, pp. 709-715, 10/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				X. Cao, L. Liang, J. R. Hadcock, P. A. Iredale, D. A. Griffith, F. S. Menniti, S. Factor, J. T. Greenamyre, and S. M. Papa Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 318 - 326. [Abstract] [Full Text] [PDF]

				M. Ginj, H. Zhang, B. Waser, R. Cescato, D. Wild, X. Wang, J. Erchegyi, J. Rivier, H. R. Macke, and J. C. Reubi Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors PNAS, October 31, 2006; 103(44): 16436 - 16441. [Abstract] [Full Text] [PDF]

				Q. Liu, R. Cescato, D. A. Dewi, J. Rivier, J.-C. Reubi, and A. Schonbrunn Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin Analogs Mol. Pharmacol., July 1, 2005; 68(1): 90 - 101. [Abstract] [Full Text] [PDF]

				H. E. Pruett, D. L. Thompson Jr., J. A. Cartmill, C. C. Williams, and L. R. Gentry Thyrotropin releasing hormone interactions with growth hormone secretion in horses J Anim Sci, September 1, 2003; 81(9): 2343 - 2351. [Abstract] [Full Text] [PDF]

				G. Weckbecker, U. Briner, I. Lewis, and C. Bruns SOM230: A New Somatostatin Peptidomimetic with Potent Inhibitory Effects on the Growth Hormone/Insulin-Like Growth Factor-I Axis in Rats, Primates, and Dogs Endocrinology, October 1, 2002; 143(10): 4123 - 4130. [Abstract] [Full Text] [PDF]

				G. Tulipano, D. Soldi, M. Bagnasco, M. D. Culler, J. E. Taylor, D. Cocchi, and A. Giustina Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment Endocrinology, April 1, 2002; 143(4): 1218 - 1224. [Abstract] [Full Text] [PDF]

				F. Abdu, G. A. Hicks, G. Hennig, J. P. Allen, and D. Grundy Somatostatin sst2 receptors inhibit peristalsis in the rat and mouse jejunum Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G624 - G633. [Abstract] [Full Text] [PDF]

				W. R. Baumbach, T. A. Carrick, M. H. Pausch, B. Bingham, D. Carmignac, I. C. A. F. Robinson, R. Houghten, C. M. Eppler, L. A. Price, and J. R. Zysk A Linear Hexapeptide Somatostatin Antagonist Blocks Somatostatin Activity In Vitro and Influences Growth Hormone Release in Rats Mol. Pharmacol., November 1, 1998; 54(5): 864 - 873. [Abstract] [Full Text]

				D. Djordjijevic, J. Zhang, M. Priam, C. Viollet, D. Gourdji, C. Kordon, and J. Epelbaum Effect of 17{beta}-Estradiol on Somatostatin Receptor Expression and Inhibitory Effects on Growth Hormone and Prolactin Release in Rat Pituitary Cell Cultures Endocrinology, May 1, 1998; 139(5): 2272 - 2277. [Abstract] [Full Text] [PDF]